ONIDA, FRANCESCO
ONIDA, FRANCESCO
Dipartimento di Oncologia ed Emato-Oncologia
Urgent need: evidence-based use of donor lymphocyte infusions – Authors' reply
2025 S. Pagliuca, C. Schmid, N. Santoro, F. Simonetta, G. Battipaglia, T. Guillaume, R. Greco, F. Onida, I. Sánchez-Ortega, I. Yakoub-Agha, F. Malard, J. Kuball, M.D. Hazenberg, A. Ruggeri
Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT
2025 N. Polverelli, J.C. Hernández-Boluda, F. Onida, C. Gurnari, K. Raj, T. Czerw, M. Kenyon, M. Robin, K. Sockel, A. Ruggeri, I. Sánchez-Ortega, D.A. Arber, L. Arcaini, F.B. Duarte, G. Battipaglia, Y. Chalandon, F. Ciceri, N.C.P. Cross, J. Drozd-Sokolowska, V. Funke, N. Gagelmann, N. Gangat, J. Gotlib, P. Guglielmelli, C. Harrison, G. Hobbs, T. Jain, J.D. Khoury, J.J. Kiladjian, N. Kröger, L. Malcovati, M. Martino, R. Mesa, A. Orazi, E. Padron, F. Palandri, F. Passamonti, M.M. Patnaik, N. Pemmaraju, D.H. Radia, A. Reiter, D. Russo, C. Scheid, A. Tefferi, A.M. Vannucchi, D.H. Wiseman, I. Yakoub-Agha, D.P. Mclornan
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial
2025 A.M. Raiola, B. Bruno, A.M. Risitano, F. Mosna, I.M. Cavattoni, F. Onida, G. Saporiti, F. Patriarca, M.L. Battista, V. Pavone, A. Mele, P. Chiusolo, S. Sica, B. Loteta, C. Di Grazia, A.M. Carella, D. Salvatore, E. Morello, A. Leoni, L. Giaccone, P. Bernasconi, E. Terruzzi, N. Mordini, C. Borghero, F. Zallio, M. Luppi, A. Grassi, A. Olivieri, E. Piras, N. Sacchi, G. Ciccone, A. Castiglione, E. Degrandi, E. Angelucci, M. Martino, F. Bonifazi
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis
2025 C. Girmenia, P. Chiusolo, G. Marsili, A. Piciocchi, M.C. Micò, R. Greco, G. Porto, F. Galaverna, F. Bonifazi, I. Cutini, M. Malagola, S. Bramanti, A. Busca, A.M. Carella, A. Carotti, A.P. Iori, F. Onida, R. Bono, E. Terruzzi, A. Vacca, A. Rinaldi, I.M. Cavattoni, A. Picardi, M. Faraci, T. Lazzarotto, F. Baldanti, P. Clerici, L. Castagna, M. Martino, F. Ciceri
Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee
2025 D. Neofytos, P.E. Verweij, D. Averbuch, M. Mikulska, J. Styczynski, J.L. Piñana, S. Cesaro, I. Sanchez-Ortega, R. Greco, F. Onida, I. Yakoub-Agha, P. Ljungman, R. De La Camara, A. Bergeron
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial
2025 F. Ravaioli, A. Colecchia, J. Peccatori, D. Pagliara, A. Grassi, F. Barbato, R. Masetti, B. Sarina, S. Sica, S. Cesaro, C. Nozzoli, G.M. Assanto, L. Prezioso, S. Santarone, F. Saglio, E. Vanni, A. Olivieri, M. Delia, E. Benedetti, F. Zallio, F. Pane, C. Skert, M. Menconi, F. Benedetti, F. De Felice, L. Colecchia, T. Belotti, L.V. Alemanni, M. Ursi, G. Marasco, M. Roberto, A. Vestito, E. Dajti, M. Garcovich, S. Bramanti, D. Taurino, F. Quagliarella, F. Ciceri, A. Prete, A. Pession, D. Festi, N. Null, M. Arpinati, E. Maffini, S. Falcione, R.M. Zagari, Z. Daniele, L. Lazzari, A. Rambaldi, L. Riccardi, V.D. Ruscio, E. Boccieri, M. Falcomer, V. Chiara, V. Vitale, C. Garonzi, F. Vizzutti, U. Arena, A.D. Santis, A. Rinaldi, A. Olivani, D. Vaddinelli, E.D. Lembo, M. Spadea, V. Apolito, D. Chiara, A. Busca, G. Mancini, G. Argalia, P. Carluccio, F. Passerini, A.D. Gangi, P. Rivela, R. Carbone, G. Battipaglia, F. Carobolante, I. Franceschet, F. Patriarca, M. Malagola, R. Varaldo, F. Onida, P. Vincenzo, F. Bonifazi, F. Bonifazi
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
2025 C.E. Graham, R. Velasco, A. Alarcon Tomas, O.P. Stewart, G. Dachy, F. Del Bufalo, M. Doglio, J. Henter, G. Ortí, Z. Peric, C. Roddie, N.W.C.J. Van De Donk, M.J. Frigault, A. Ruggeri, F. Onida, I. Sánchez-Ortega, I. Yakoub-Agha, O. Penack
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
2025 C. Gurnari, M. Robin, L. Adès, M. Aljurf, A. Almeida, F.B. Duarte, E. Bernard, C. Cutler, M.G. Della Porta, T. De Witte, A. Dezern, J. Drozd-Sokolowska, E. Duncavage, P. Fenaux, N. Gagelmann, G. Garcia-Manero, C. Haferlach, T. Haferlach, R. Hasserjian, E. Hellström-Lindberg, M. Jacoby, A. Kulasekararaj, R.C. Lindsley, J.P. Maciejewski, H. Makishima, L. Malcovati, M. Mittelman, A.E. Myhre, S. Ogawa, F. Onida, E. Papaemmanuil, J. Passweg, U. Platzbecker, L. Pleyer, K. Raj, V. Santini, A. Sureda, M. Tobiasson, M.T. Voso, I. Yakoub-Agha, A. Zeidan, M. Walter, N. Kröger, D.P. Mclornan, M. Cazzola
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
2025 G. Ortí, G. Dachy, C.E. Graham, Z. Peric, A. Alarcon, F. Del Bufalo, M. Doglio, J. Henter, C. Roddie, O. Stewart, W.C.J. Van De Donk, R. Velasco, M. Aljurf, A. Ruggeri, F. Onida, I. Sánchez-Ortega, I. Yakoub-Agha, O. Penack
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry‐Based Study on Behalf of the “Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare” (GITMO)
2025 I. Defrancesco, V.V. Ferretti, P. Chiusolo, D. Russo, C. Nozzoli, A. Olivieri, M. Gambella, I.M. Cavattoni, S. Bramanti, S. Santarone, R. Fanin, R. Cairoli, S. Piemontese, M. Parma, F. Onida, A. Busca, L. Castagna, A. Cuoghi, D. Pastore, N. Mordini, F. Benedetti, C. Skert, C. Borghero, A.P. Iori, F. Fagioli, V. Pavone, C. Selleri, S. Cesaro, M. Musso, M. Ladetto, D. Vallisa, P. Carluccio, A. Picardi, M. Tozzi, A. Biffi, G. Milone, M. Faraci, A. Prete, L. Prezioso, A.M. Risitano, F.P. Tambaro, V. Tintori, P. Galieni, F. Pane, C. Zerbi, A. Bianchessi, G. Losi, F. Romano, A. Taurino, E. Oldani, N. Polverelli, F. Bonifazi, M. Martino
BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia
2025 A. Tefferi, S. Fathima, M. Abdelmagid, A. Alsugair, F. Aperna, M. Rezasoltani, M. Yousuf, A. Natu, C.M. Csizmar, M. Gurney, T.L. Lasho, C.M. Finke, R. Kanagal-Shamanna, D. Hammond, K.S. Chien, A. Bazinet, C.D. Dinardo, T.M. Kadia, A.A. Mangaonkar, N.G. Daver, A.D. Pardanani, G. Borthakur, C.J. Zepeda-Mendoza, K.K. Reichard, R. He, S. Loghavi, F. Passamonti, F. Ravandi, K. Sasaki, D. Larson, G. Garcia-Manero, F. Onida, N. Gangat, G. Montalban-Bravo, M.M. Patnaik
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review
2024 G. Avallone, G. Roccuzzo, A. Pileri, C. Agostinelli, C.A. Maronese, C. Aquino, G. Tavoletti, F. Onida, P. Fava, S. Ribero, A.V. Marzano, E. Berti, P. Quaglino, S. Alberti‐violetti
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents
2024 N. Del Papa, S. Cavalli, A. Rindone, F. Onida, G. Saporiti, A. Minniti, M.R. Pellico, C. Iannone, G. Trignani, N. D'Angelo, M. Sette, R. Greco, C. Vitali, R. Caporali
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT
2024 C. Gurnari, L. Koster, L. Baaij, M. Heiblig, I. Yakoub-Agha, M. Collin, J. Passweg, C.E. Bulabois, A. Khan, M. Loschi, F. Carnevale-Schianca, E. Crisà, D. Caravelli, J. Kuball, F. Saraceni, A. Olivieri, A. Rambaldi, A.G. Kulasekararaj, P.J. Hayden, M. Badoglio, F. Onida, C. Scheid, F. Franceschini, A. Mekinian, S. Savic, M.T. Voso, J. Drozd-Sokolowska, J.A. Snowden, K. Raj, T. Alexander, M. Robin, R. Greco, D.P. Mclornan
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)
2024 C. Niederwieser, S. Iacobelli, G. Franke, L. Koster, M. Van Os, U. Platzbecker, K. Hübel, C. Scheid, L.P. Müller, M. Stelljes, E. Morozova, J. Passweg, F. Onida, P. Dreger, R. Saccardi, M. Ladetto, U. Salmenniemi, W. Bethge, X. Poiré, G. Kobbe, D.P. Mclornan, M. Robin, N. Kröger
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial
2024 D. Russo, N. Polverelli, S. Bernardi, S. Santarone, M. Farina, E. Borlenghi, F. Onida, L. Castagna, S. Bramanti, A.M. Carella, R. Sorasio, M. Martino, C. Alati, A. Olivieri, G. Beltrami, A. Curti, C. Vetro, S. Leotta, V. Mancini, E. Terruzzi, M. Bernardi, P. Galieni, P. Musto, R. Cerretti, L. Giaccone, C. Skert, V. Radici, M. Vezzoli, S. Calza, A. Leoni, L. Garuffo, C. Bonvicini, S. Pellizzeri, M. Malagola, F. Ciceri
Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients: Recommendations from the EBMT practice harmonization and guidelines committee
2024 J.L. Piñana, S. Cesaro, M. Mikulska, P.E. Verweij, A. Bergeron, D. Neofytos, J. Styczynski, I. Sánchez-Ortega, R. Greco, F. Onida, I. Yakoub-Agha, D. Averbuch, R.D.L. Cámara, P. Ljungman
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms
2024 Y. Chalandon, D. Eikema, I. Moiseev, F. Ciceri, L. Koster, J. Vydra, J. Passweg, M. Rovira, T. Ozcelik, T. Gedde-Dahl, N. Kröger, V. Potter, I. Yakoub-Agha, A. Rambaldi, M. Itälä-Remes, A. Tanase, F. Onida, C. Gurnari, C. Scheid, J. Drozd-Sokolowska, K. Raj, D.P. Mclornan, M. Robin
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT
2024 F. Onida, L. Gras, J. Ge, L. Koster, R. Hamladji, J. Byrne, D. Avenoso, M. Aljurf, M. Robin, K. Halaburda, J. Passweg, U. Salmenniemi, H. Sengeloev, J. Apperley, A. Clark, P. Reményi, E. Morozova, F. Kinsella, S. Lenhoff, A. Ganser, K.L. Wu, A. Perez‐martinez, P.J. Hayden, K. Raj, J. Drozd‐sokolowska, G. Ortí, H. De Lavallade, I. Yakoub‐agha, D.P. Mclornan, Y. Chalandon
Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences
2024 S. Alberti Violetti, M. Ardigò, P. Fava, G. Gritti, E. Morsia, F. Onida, M. Paulli, A. Pileri, P. Quaglino, S. Rupoli, M. Teoli, P. Vezzoli